Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Depreciation and Depletion (2020 - 2025)

Celularity has reported Depreciation and Depletion over the past 5 years, most recently at $1.4 million for Q3 2025.

  • Quarterly results put Depreciation and Depletion at $1.4 million for Q3 2025, down 4.67% from a year ago — trailing twelve months through Sep 2025 was $5.9 million (down 8.36% YoY), and the annual figure for FY2024 was $6.2 million, down 13.49%.
  • Depreciation and Depletion for Q3 2025 was $1.4 million at Celularity, down from $1.5 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for CELU hit a ceiling of $2.1 million in Q4 2021 and a floor of $1.4 million in Q1 2021.
  • Median Depreciation and Depletion over the past 4 years was $1.5 million (2024), compared with a mean of $1.6 million.
  • Biggest five-year swings in Depreciation and Depletion: surged 60.22% in 2021 and later decreased 8.94% in 2025.
  • Celularity's Depreciation and Depletion stood at $2.1 million in 2021, then fell by 15.14% to $1.7 million in 2022, then dropped by 13.94% to $1.5 million in 2024, then decreased by 3.47% to $1.4 million in 2025.
  • The last three reported values for Depreciation and Depletion were $1.4 million (Q3 2025), $1.5 million (Q2 2025), and $1.5 million (Q1 2025) per Business Quant data.